Current status and problems in preclinical assessment of immunomodulators
Developments in biological standardization.
1992 ;
77 () :
103-9.
Language English Country Switzerland Media print
Document type Journal Article, Review
Persistent link
https://www.medvik.cz/link/pmid01426649
PubMed
1426649
Knihovny.cz E-resources
- MeSH
- Acetylmuramyl-Alanyl-Isoglutamine pharmacology MeSH
- Adjuvants, Immunologic standards therapeutic use toxicity MeSH
- Amantadine analogs & derivatives pharmacology MeSH
- Dipeptides pharmacology MeSH
- Dose-Response Relationship, Immunologic MeSH
- Immunotherapy MeSH
- Mice MeSH
- Predictive Value of Tests MeSH
- Drug Evaluation, Preclinical methods standards MeSH
- Graft vs Host Reaction drug effects MeSH
- DNA Replication drug effects MeSH
- Reproducibility of Results MeSH
- Sensitivity and Specificity MeSH
- Thymidine Kinase antagonists & inhibitors MeSH
- Structure-Activity Relationship MeSH
- Inflammation chemically induced MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Acetylmuramyl-Alanyl-Isoglutamine MeSH
- adamantylamide-alanyl-isoglutamine MeSH Browser
- Adjuvants, Immunologic MeSH
- Amantadine MeSH
- Dipeptides MeSH
- Thymidine Kinase MeSH
